Optimizing CDPK1 inhibitors for chronic toxoplasmosis

March 1st, 2022 – Jim Janetka, PhD, Professor in Biochemistry and Molecular Biophysics and David Sibley, Professor in Molecular Microbiology received a new five-year grant R01 award from the National Institute of Allergy and Infectious Diseases (NIAID) of the NIH totaling 3.9 million dollars for their research entitled “Optimizing CDPK1 inhibitors for chronic toxoplasmosis”.